PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$31.73 USD
+0.80 (2.59%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $31.74 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PTCT 31.73 +0.80(2.59%)
Will PTCT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PTCT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PTCT
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
PTCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Other News for PTCT
Nike, Kura Sushi fall; Infinera, Protagonist Therapeutics rise, Friday, 6/28/2024
Sell Rating on PTC Therapeutics Amid Persistent Regulatory Hurdles for Translarna
Buy Rating for PTC Therapeutics: Translarna’s Continued EU Market Presence and Global Expansion Potential
Buy Rating on PTC Therapeutics: Market Overreaction and Opportunity Amidst CHMP Review
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session